| abstract |
In order to efficiently promote angiogenesis in the treatment of ischemic diseases with an HGF plasmid, a diagnostic agent capable of imaging an administration site with the highest therapeutic effect, that is, an HGF receptor expression site, is provided. Heparin binding activity, which is a partial polypeptide of hepatocyte growth factor, comprising a polypeptide containing a heparin binding region, or an amino acid sequence in which one or several amino acids of the polypeptide are substituted, deleted or added A diagnostic agent for a disease involving a hepatocyte growth factor receptor, which comprises a labeled form of a polypeptide having the above. |